Category: snoring and apnea

Investigational Nerve Stimulator for Obstructive Sleep Apnea: Surgical Technique Description and Case Study Report Published 0

Investigational Nerve Stimulator for Obstructive Sleep Apnea: Surgical Technique Description and Case Study Report Published

Data demonstrating the benefits and safety of Nyxoah SA’s Genio hypoglossal nerve stimulation system implantation technique for the treatment of obstructive sleep apnea (OSA) have been published in Laryngoscope Investigative Otolaryngology.

The Genio system, which has received CE mark approval in Europe and is investigational in the United States, offers bilateral stimulation of the hypoglossal nerve branches, which the company states may lead to potentially greater airway opening than implants that comprise a cuff electrode wrapped around the hypoglossal nerve.

This study describes the surgical implantation of the Genio nerve stimulator, which involves one incision in the chin area and no internal battery.

The recently completed clinical study (the BLAST OSA study) also provides evidence as to the acceptable safety profile and the therapeutic benefits of the Genio system.

Lead author Richard Lewis, MBBS, FRACS, head & neck surgeon, says in a release, “Unlike other commercially available devices for OSA, which involve multiple incision sites, the Genio system only requires a minimal surgical procedure, with one incision site beneath the chin. The results from the BLAST OSA study have

How Does Sleep Deprivation Affect The Body? 0

How Does Sleep Deprivation Affect The Body?

Is something, or are some things keeping you up? Maybe you’ve had a lot of coffee than you normally do, or maybe you are having insomnia for some reason. If you are not getting the recommended hours of sleep a day, you won’t just feel tired, cranky, and moody the next day. Sleep deprivation has other effects too.


Sleep is an important part of everyday life. It is just as important as eating. The body won’t last for too long if left without sleep. In other words, it is crucial. But it isn’t just the hours of sleep that you get that should be paid attention to. It’s also the quality of it. Other than making the brain hazy, sleep deprivation can adversely affect other parts of the body as well.


The brain is a part of a bigger system called the Central Nervous System. Brain cells travel and function within it. A deprivation in sleep can cause fatigue in the brain.

During sleep, pathways form between nerve cells (neurons) in your brain that help you remember new

How Sleep Apnea Can Affect Your Diabetes Risk 0

How Sleep Apnea Can Affect Your Diabetes Risk

Some believe diabetes is primarily a body weight issue, but studies have shown that more so than weight, the severity of the sleeping disorder can elevate someone with sleep apnea’s risk of developing diabetes, reports CBS 13 WJZ.

“One of the things the body does when we don’t get good sleep is release stress hormones during the day. When you don’t sleep well, and when morning comes and we have to get up and function, our body releases all of these catecholamines, or stress hormones, to keep us awake,” Xenakis says. “

from Sleep Review…

Venture Capital Invests in Non-surgical Neurostimulator for Obstructive Sleep Apnea 0

Venture Capital Invests in Non-surgical Neurostimulator for Obstructive Sleep Apnea

UAVenture Capital Fund (UAVC), a venture capital fund dedicated to the commercialization of University of Arizona discoveries, products, technologies, and services, has invested in StimAire Inc. StimAire is developing a wireless, wearable, non-surgical, targeted neurostimulator for obstrutive sleep apnea (OSA). Its design includes a wearable and a tiny injectable device. The total market opportunity for StimAire’s neural stimulation includes treatments for OSA, bladder control, epilepsy, Parkinson’s, and central and peripheral pain.

Abhay Sanan, MD, a neurosurgeon with the Center for Neurosciences and clinical assistant professor in both the Division of Neurosurgery and the Department of Radiation Oncology at the University of Arizona is the company’s chief medical officer.

Sairam Parthasarathy, MD, chief of the University of Arizona Division of Pulmonology, Allergy, Critical Care and Sleep Medicine, is the principal investigator of the company’s human clinical studies.

Tarek Makansi PhD, president and chief technology officer of StimAire, says in a release, “As a serial entrepreneur, I’m thrilled to be part of the UAVC funding that is making a pivotal advancement in our startup economy. StimAire will now develop therapies that can

How Important Is Sleep To Children? 0

How Important Is Sleep To Children?

Kids do get sleep. In fact, babies sleep almost all the time. While adults need the recommended 7-9 hours of sleep a day, babies need 2/3 of the day sleeping.

As children grow older, the amount of sleep they need varies:

  • toddlers: 11 to 14 hours
  • preschoolers: 10 to 13 hours
  • school-aged children: 9 to 12 hours
  • teens: 8 to 10 hours


Children need to have good quality and quantity of sleep simply because they are growing. And sleep helps support their growth stage. A lot of things can happen during the growth stage. They will need all the help they can get for optimum growth. And sleep is one of them.


Deep sleep stimulates growth, especially in babies.

“Growth hormone is primarily secreted during deep sleep,” says Judith Owens, M.D., director of sleep medicine at Children’s National Medical Center, in Washington, D.C., and a Parents advisor. Mother Nature seems to have protected babies by making sure they spend about 50 percent of their time in this deep sleep, considered to be essential for adequate growth.

Smoking, Alcohol, Sleep Apnea All Linked to Atrial Fibrillation 0

Smoking, Alcohol, Sleep Apnea All Linked to Atrial Fibrillation

During the American Heart Association (AHA) 2019 Scientific Sessions, cardiac electrophysiology fellow Kevin Trulock, MD, explained what some of the proven risk factors are for AFib, reports MD Mag.

“Across the board the observational data that we do have is consistent in the treatment of sleep apnea is associated with AF outcomes,” Trulock said. “In a study of those undergoing cardioversion for A-fib had in common sleep apnea.”

from Sleep Review…

Sleep: What You Need To Know 0

Sleep: What You Need To Know

Mankind has never been busier before than they are now. Today is all about hustling. And it is becoming a norm. At work, there are a lot of things that need to be done in a short period of time. The same goes at home. Getting sleep is almost a luxury. Time ticks so fast that often times we have a hard time getting a hold of it. But if you don’t know it yet, sleep is a vital part of life.


Sleep, more specifically enough sleep and good quality sleep, is crucial so you could work efficiently and safely. Not getting enough of it can lead to many problems.

According to the NSF, these are some of the ramifications of sleep problems:

  • Decreased alertness and attentiveness
  • Increased irritability and relationship difficulties
  • Decreased concentration and judgment
  • Decreased performance and productivity
  • Increased risk of accidents



Sleep deprivation can cause lessen work efficiency and competence. It can also affect relationships. And most of all, it can get you in an unwanted accident. So if you want to …

AASM Issues Position Statement on Chronic Opioid Therapy and Sleep 0

AASM Issues Position Statement on Chronic Opioid Therapy and Sleep

Patients and medical providers should be aware that chronic opioid use can interfere with sleep by reducing sleep efficiency and increasing the risk of sleep-disordered breathing, according to a position statement from the American Academy of Sleep Medicine (AASM).

In addition to understanding the risks of opioid addiction and abuse, it is important for health care providers to be aware that chronic opioid use is associated with changes in sleep architecture and an increased risk of respiratory depression during sleep.

“This statement increases awareness among health care providers of the important adverse events that can occur in patients on chronic opioid therapy,” says co-author R. Nisha Aurora, MD, associate professor of medicine at Rutgers Robert Wood Johnson Medical School in New Jersey, in a release. “The paper also highlights the need for providers to recognize and diagnose sleep-related breathing disorders that are frequently seen with chronic opioid use.”

The position statement was developed by the AASM board of directors and is published in the Nov 15 issue of the Journal of Clinical Sleep Medicine.

Patients who have chronic

Keep an Eye on These Sleep Companies That Made the Inc. 5000 0

Keep an Eye on These Sleep Companies That Made the Inc. 5000

Inc. has published its annual guide to the 5,000 fastest-growing privately held companies in the United States. Here are the sleep companies that made the prestigious list.

#96: Amenity Health, a maker of a positional therapies, among other devices. Its website states, “A small pilot study conducted by a sleep laboratory, showed that the position created by the MedCline Reflux Relief product line reduced AHI in mild-moderate positional sleep apnea patients. Future clinical studies will further validate MedCline as an effective, natural treatment for positional sleep apnea.”

#1,003: ProSomnus Sleep Technologies, a maker of custom oral appliances for sleep apnea. “Dental sleep medicine providers, sleep boarded physicians, patients, and our employees are the reason ProSomnus made the prestigious Inc. 5000 list of America’s fastest growing companies,” says Len Liptak, CEO of ProSomnus, in a release. “The entire ProSomnus team is truly grateful that a growing number of care providers are prescribing and entrusting ProSomnus Sleep Devices for their patients with OSA.”

#1,797: 3B Medical, a maker of CPAP and oxygen devices and accessories. “One of 3B

European Medicines Agency Committee Recommends Jazz Pharmaceuticals’ Solriamfetol for Marketing Authorization 0

European Medicines Agency Committee Recommends Jazz Pharmaceuticals’ Solriamfetol for Marketing Authorization

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the marketing authorization of Jazz Pharmaceuticals’ solriamfetol to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adults with narcolepsy (with or without cataplexy) or obstructive sleep apnea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy.

“Today’s positive CHMP opinion is an important milestone for people living with EDS associated with narcolepsy or OSA, which has been shown to negatively impact the lives of people living with these conditions,” says Robert Iannone, MD, MSCE, executive vice president, research and development of Jazz Pharmaceuticals, in a release. “This milestone brings us one step closer to potentially providing a new treatment option for people living with these sleep disorders in Europe.”

The Marketing Authorisation Application (MAA) for solriamfetol is based on data from four randomized placebo-controlled studies included in the Treatment of Obstructive sleep apnea and Narcolepsy Excessive Sleepiness (TONES) clinical trial program. Data from the studies in the TONES program demonstrated the superiority of solriamfetol relative to placebo.